Clearmind Medicine Inc. (CMND)
USD 1.15
(-10.16%)
USD 1.15
(-10.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.57 Million | -5.08 Million | -2.83 Million | -264.45 Thousand | -63 Thousand | -105.58 Thousand |
| Net Income | -6.26 Million | -9.41 Million | -3.89 Million | -233.22 Thousand | -105.28 Thousand | -194.53 Thousand |
| Depreciation & Amortization | 41.77 Thousand | 113.37 Thousand | 2572.00 | 179.69 | - | - |
| Deferred income taxes | 12.61 Thousand | 40.75 Thousand | - | - | - | - |
| Stock-based compensation | 192.45 Thousand | 887.29 Thousand | 500.23 Thousand | - | - | 147.3 Thousand |
| Change in working capital | -703.89 Thousand | 1.68 Million | 25.98 Thousand | -31.23 Thousand | 42.27 Thousand | 1645.00 |
| Other non-cash items | 2.06 Million | 836.94 Thousand | 189.68 Thousand | 28.00 | -5353.00 | -60 Thousand |
| Investing Cash Flow | -19.05 Thousand | -7593.00 | -251.18 Thousand | -5095.00 | -10 Thousand | -131.17 Thousand |
| Investments in PPE | - | -7593.00 | -231.18 Thousand | -10 Thousand | -10 Thousand | -131.17 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -25.69 Thousand | - | -20 Thousand | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 6643.53 | -7.59 Million | -14.65 Thousand | 4905.00 | - | - |
| Financing Cash Flow | 8.47 Million | 698.4 Thousand | 7.35 Million | 598.7 Thousand | - | 208 Thousand |
| Debt repayment | -29.72 Thousand | -77.03 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 8.07 Million | 795.13 Thousand | 7.72 Million | 650 Thousand | - | 210 Thousand |
| Other Financing Activities | 428.62 Thousand | -19.69 Thousand | -369.18 Thousand | -51.3 Thousand | - | -2000.00 |
| Accounts receivables | -151.48 Thousand | 27.21 Thousand | -157.74 Thousand | -28.00 | 5353.00 | -8080.00 |
| Accounts payables | -450.66 Thousand | 1.24 Million | 343.59 Thousand | -7444.00 | 5099.00 | 6575.00 |
| Inventory | 151.48 Thousand | -27.21 Thousand | 157.74 Thousand | 28.00 | -5353.00 | - |
| Other working capital | -253.22 Thousand | 441.41 Thousand | -317.6 Thousand | -23.78 Thousand | 37.17 Thousand | -4930.00 |
| Cash at beginning of period | 93.54 Thousand | 4.59 Million | 329.84 Thousand | 688.00 | 73.69 Thousand | 102.45 Thousand |
| Cash at end of period | 3.94 Million | 175.76 Thousand | 4.61 Million | 329.84 Thousand | 688.00 | 73.69 Thousand |
| Capital Expenditure | - | -7593.00 | -231.18 Thousand | -10 Thousand | -10 Thousand | -131.17 Thousand |
| Effect of forex changes on cash | -27.4 Thousand | -30.91 Thousand | 20 Thousand | - | - | - |
| Net cash flow / Change in cash | 3.84 Million | -4.42 Million | 4.28 Million | 329.15 Thousand | -73 Thousand | -28.76 Thousand |
| Free Cash Flow | -4.57 Million | -5.09 Million | -3.06 Million | -274.45 Thousand | -73 Thousand | -236.76 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.09 Million | -908.21 Thousand | -1.36 Million | -2.95 Million | -6.26 Million | -430.81 Thousand |
| Depreciation & Amortization | 15.19 Thousand | 15.73 Thousand | 8631.00 | 2917.90 | 41.77 Thousand | 13.41 Thousand |
| Deferred income taxes | -31.47 Thousand | -130.26 Thousand | 201.5 Thousand | 8246.67 | 12.61 Thousand | -4966.66 |
| Stock-based compensation | 377.27 Thousand | 290.09 Thousand | 34 Thousand | 12.14 Thousand | 192.45 Thousand | 1329.58 |
| Change in working capital | -50.6 Thousand | -57.51 Thousand | -296.1 Thousand | 279.52 Thousand | -703.89 Thousand | -329.91 Thousand |
| Other non-cash items | 2295.00 | 1628.00 | 1.00 | 2.09 Million | 2.06 Million | -339.95 Thousand |
| Investing Cash Flow | 33.8 Thousand | 108.07 | - | -24.63 Thousand | -19.05 Thousand | 5756.87 |
| Investments in PPE | 1.75 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -25.69 Thousand | -25.69 Thousand | - |
| Sales/Maturities of investments | 33.25 Thousand | - | - | - | - | 7760.46 |
| Other Investing Activities | 33.8 Thousand | 108.07 | - | 1060.52 | 6643.53 | -2003.59 |
| Financing Cash Flow | 469.53 Thousand | 145.12 Thousand | 5.31 Million | 1.74 Million | 8.47 Million | -23.73 Thousand |
| Debt repayment | -13.46 Thousand | -12.78 Thousand | -6298.00 | -930.58 | -29.72 Thousand | -7443.63 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 103.38 Thousand | - | 1.82 Million | 1.31 Million | 8.07 Million | -16.28 Thousand |
| Other Financing Activities | -13.3 Thousand | 217.41 | 7155.34 | 428.62 Thousand | 428.62 Thousand | -31.29 |
| Accounts receivables | -17.45 Thousand | -29.59 | 125.79 | -1118.95 | -151.48 Thousand | -53.61 Thousand |
| Accounts payables | - | - | - | 202.2 Thousand | -450.66 Thousand | -369.11 Thousand |
| Inventory | - | - | - | 1118.95 | 151.48 Thousand | 53.61 Thousand |
| Other working capital | -31.31 Thousand | 2.90 | 109.17 Thousand | 77.31 Thousand | -253.22 Thousand | 39.2 Thousand |
| Cash at beginning of period | 8.3 Million | 9.28 Million | 5.42 Million | 2.79 Million | 93.54 Thousand | 3.92 Million |
| Cash at end of period | 7.67 Million | 8.3 Million | 9.28 Million | 3.94 Million | 3.94 Million | 2.88 Million |
| Capital Expenditure | 1.75 | - | - | - | - | - |
| Effect of forex changes on cash | -2878.00 | -10.89 Thousand | 3723.00 | -27.39 Thousand | -27.4 Thousand | 904.05 |
| Net cash flow / Change in cash | -626.27 Thousand | -980.04 Thousand | 3.85 Million | 1.14 Million | 3.84 Million | -1.04 Million |
| Free Cash Flow | -1.12 Million | -1.19 Million | -1.46 Million | -547.09 Thousand | -4.57 Million | -1.03 Million |
8188
CLIG
MEIL
VTYB
PV1
THAFF